UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

Gastroenterology (New York, N.Y. 1943), 2009-01, Vol.136 (1), p.138-148

2009

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response

Gastroenterology (New York, N.Y. 1943), 2016-12, Vol.151 (6), p.1131-1140.e5

2016

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

Gastroenterology (New York, N.Y. 1943), 2016-02, Vol.150 (2), p.419-429

2016

Link zum Volltext

Verfügbarkeit prüfen

Liver Transplantation for Hepatocellular Carcinoma

Gastroenterology (New York, N.Y. 1943), 2005-05, Vol.128 (6), p.1752-1764

2005

Link zum Volltext

Verfügbarkeit prüfen

Hepatocellular carcinoma: Diagnosis and treatment

Gastroenterology (New York, N.Y. 1943), 2002-05, Vol.122 (6), p.1609-1619

2002

Link zum Volltext

Verfügbarkeit prüfen

Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy

Gastroenterology (New York, N.Y. 1943), 1999-11, Vol.117 (5), p.1229-1233

1999

Link zum Volltext

Verfügbarkeit prüfen

Issues in screening and surveillance for hepatocellular carcinoma

Gastroenterology (New York, N.Y. 1943), 2004-11, Vol.127 (5), p.S104-S107

di Bisceglie, Adrian M.

2004

Link zum Volltext

Verfügbarkeit prüfen

Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment

Gastroenterology (New York, N.Y. 1943), 2004-04, Vol.126 (4), p.1015

2004

Link zum Volltext

Verfügbarkeit prüfen

Roles of Iron and HFE Mutations on Severity and Response to Therapy During Retreatment of Advanced Chronic Hepatitis C

Gastroenterology (New York, N.Y. 1943), 2006-11, Vol.131 (5), p.1440-1451

2006

Link zum Volltext

Verfügbarkeit prüfen

Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the HALT-C Trial

Gastroenterology (New York, N.Y. 1943), 2009-12, Vol.137 (6), p.1986-1994

2009

Link zum Volltext

Verfügbarkeit prüfen

Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C

Gastroenterology (New York, N.Y. 1943), 1995-04, Vol.108 (4), p.1104-1109

1995

Link zum Volltext

Verfügbarkeit prüfen

Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma

Gastroenterology (New York, N.Y. 1943), 2010-02, Vol.138 (2), p.493-502

2010

Link zum Volltext

Verfügbarkeit prüfen

Maintenance Peginterferon Therapy and Other Factors Associated With Hepatocellular Carcinoma in Patients With Advanced Hepatitis C

Gastroenterology (New York, N.Y. 1943), 2011-03, Vol.140 (3), p.840-849.e1

2011

Link zum Volltext

Verfügbarkeit prüfen

Impact of Reducing Peginterferon Alfa-2a and Ribavirin Dose During Retreatment in Patients With Chronic Hepatitis C

Gastroenterology (New York, N.Y. 1943), 2007, Vol.132 (1), p.103-112

2007

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Immunotherapy With TG4040, Peg-Interferon, and Ribavirin in a Phase 2 Study of Patients With Chronic HCV Infection

Gastroenterology (New York, N.Y. 1943), 2014-07, Vol.147 (1), p.119-131.e3

2014

Link zum Volltext

Verfügbarkeit prüfen

Predicting Clinical and Histologic Outcomes Based on Standard Laboratory Tests in Advanced Chronic Hepatitis C

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (1), p.136-146

2010

Link zum Volltext

Verfügbarkeit prüfen

Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C

Gastroenterology (New York, N.Y. 1943), 1992-04, Vol.102 (4), p.1406-1408

1992

Link zum Volltext

Verfügbarkeit prüfen

What every hepatologist should know about endocrinology: Obesity, diabetes, and liver disease

Gastroenterology (New York, N.Y. 1943), 2004-02, Vol.126 (2), p.604-606

Di Bisceglie, Adrian M.

2004

Link zum Volltext

Verfügbarkeit prüfen

808 HBeAg(+) Immune Tolerant Phenotype Is Rare Among Children In The Largest US-Canadian Cohort With Chronic HBV Infection

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S1048-S1048

2016

Link zum Volltext

Verfügbarkeit prüfen

Factors That Determine the Development and Progression of Gastroesophageal Varices in Patients With Chronic Hepatitis C

Gastroenterology (New York, N.Y. 1943), 2010-06, Vol.138 (7), p.2321-2331.e2

2010

Link zum Volltext

Verfügbarkeit prüfen

Measurements of iron status in patients with chronic hepatitis

Gastroenterology (New York, N.Y. 1943), 1992-06, Vol.102 (6), p.2108-2113

1992

Link zum Volltext

Verfügbarkeit prüfen

Print and Media Review

Gastroenterology (New York, N.Y. 1943), 2009-02, Vol.136 (2), p.726-727

Di Bisceglie, Adrian M

2009

Link zum Volltext

Verfügbarkeit prüfen

Evolution of hepatitis C viral quasispecies after liver transplantation

Gastroenterology (New York, N.Y. 1943), 2002-11, Vol.123 (5), p.1485-1493

2002

Link zum Volltext

Verfügbarkeit prüfen

235 SAPPHIRE II: Phase 3 Placebo-Controlled Study of Interferon-Free, 12-Week Regimen of ABT-450/r/ABT-267, ABT-333, and Ribavirin in 394 Treatment-Experienced Adults With Hepatitis C Virus Genotype 1

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-904-S-904

2014

Link zum Volltext

Verfügbarkeit prüfen

236 All Oral Fixed-Dose Combination Sofosbuvir/Ledipasvir With or Without Ribavirin for 12 or 24 Weeks in Treatment-Experienced Genotype 1 HCVInfected Patients: The Phase 3 Ion-2 Study

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-904-S-904

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 77

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieGastroenterology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(75)
Reviews
(2)

Sprache

Englisch
(77)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

IngentaConnect_期刊（NSTL购买）
(77)
Elsevier ScienceDirect Journals Complete
(77)
Single Journals
(77)
MEDLINE
(34)
IngentaConnect Journals
(27)

Menü

Weitere Dienste

Einstellungen

Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

Liver Transplantation for Hepatocellular Carcinoma

Hepatocellular carcinoma: Diagnosis and treatment

Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy

Issues in screening and surveillance for hepatocellular carcinoma

Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment

Roles of Iron and HFE Mutations on Severity and Response to Therapy During Retreatment of Advanced Chronic Hepatitis C

Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the HALT-C Trial

Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C

Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma

Maintenance Peginterferon Therapy and Other Factors Associated With Hepatocellular Carcinoma in Patients With Advanced Hepatitis C

Impact of Reducing Peginterferon Alfa-2a and Ribavirin Dose During Retreatment in Patients With Chronic Hepatitis C

Efficacy of Immunotherapy With TG4040, Peg-Interferon, and Ribavirin in a Phase 2 Study of Patients With Chronic HCV Infection

Predicting Clinical and Histologic Outcomes Based on Standard Laboratory Tests in Advanced Chronic Hepatitis C

Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C

What every hepatologist should know about endocrinology: Obesity, diabetes, and liver disease

808 HBeAg(+) Immune Tolerant Phenotype Is Rare Among Children In The Largest US-Canadian Cohort With Chronic HBV Infection

Factors That Determine the Development and Progression of Gastroesophageal Varices in Patients With Chronic Hepatitis C

Measurements of iron status in patients with chronic hepatitis

Print and Media Review

Evolution of hepatitis C viral quasispecies after liver transplantation

235 SAPPHIRE II: Phase 3 Placebo-Controlled Study of Interferon-Free, 12-Week Regimen of ABT-450/r/ABT-267, ABT-333, and Ribavirin in 394 Treatment-Experienced Adults With Hepatitis C Virus Genotype 1

236 All Oral Fixed-Dose Combination Sofosbuvir/Ledipasvir With or Without Ribavirin for 12 or 24 Weeks in Treatment-Experienced Genotype 1 HCVInfected Patients: The Phase 3 Ion-2 Study

Aktive Filter

Suchergebnisse filtern